Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in Australia
Authors:
- Demi MarkakisDMDemi Markakis
- Alexis Ceecee Britten-JonesABAlexis Ceecee Britten-Jones
- Robyn H. GuymerRGRobyn H. Guymer
- Thomas L. EdwardsTEThomas L. Edwards
- Anthony J. HallAHAnthony J. Hall
- Nathan M. KerrNKNathan M. Kerr
- Weng NgWNWeng Ng
- Simon SkalickySSSimon Skalicky
- Lauren N. AytonLALauren N. Ayton
- Heather G. MackHMHeather G. Mack
Open Access
- 12 March 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 8528
Abstract
Accurate diagnosis of both age-related macular degeneration (AMD) and inherited retinal diseases (IRD) with macular atrophy is important because treatments for both conditions are emerging. Phenotypical similarities between macular atrophy associated with AMD (geographic atrophy, GA) and IRD-associated atrophy exist, which can make accurate diagnosis challenging in clinical practice. Misdiagnosis may lead to inappropriate treatment strategies and missed opportunities for disease-specific interventions. A retrospective clinical review of medical records of people diagnosed with AMD between 1995 and 2023 from a large multidisciplinary private ophthalmic practice in Australia was undertaken to identify cases of patients diagnosed with geographic atrophy without drusen, which was then further assessed for potentially missed IRD with macular atrophy. Flagged cases were presented to experts in AMD and IRD to establish a most-likely diagnosis. Cases without consensus between graders were grouped into most-likely diagnosis by a third senior retinal clinician. Of the 1136 cases reviewed, the possible rate of misdiagnosis observed was 1.9%, with 1.0% representing potentially missed IRDs, most commonly pattern dystrophy (0.5%). A multi-modal approach, including clinical features and patient history, is important to limit the possibility of misdiagnosis of GA, and identify a subset of patients who might benefit from genetic testing prior to considering possible treatments.Keywords
Funding Information
- Cabrini Medical Staff Scholarship
- University of Melbourne (Postdoctoral Scholarship, Driving Research Momentum Fellowship)
- State Government of Victoria (Operational Infrastructure Support Program, Operational Infrastructure Support Program, Operational Infrastructure Support Program, Operational Infrastructure Support Program)
- National Health and Medical Research Council (1195713)
This publication has 48 references indexed in Scilit:
- Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and BeyondOphthalmology and Therapy, 2023
- Drusen morphometrics on optical coherence tomography in eyes with age-related macular degeneration and normal agingGraefe's Archive for Clinical and Experimental Ophthalmology, 2023
- The Diagnostic Yield of Next Generation Sequencing in Inherited Retinal Diseases: A Systematic Review and Meta-analysisAmerican Journal of Ophthalmology, 2022
- The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: A systematic reviewGenetics in Medicine, 2022
- Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal DegenerationBioDrugs, 2020
- Anti-vascular endothelial growth factor for neovascular age-related macular degenerationCochrane Database of Systematic Reviews, 2019
- Macular atrophy in a case of abetalipoproteinemia as only ocular clinical featureCanadian Journal of Ophthalmology, 2015
- Clinical Classification of Age-related Macular DegenerationOphthalmology, 2013
- Patient Record Review of the Incidence, Consequences, and Causes of Diagnostic Adverse EventsArchives of internal medicine (1960), 2010
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009